Bank of Montreal
RPRX icon

Bank of Montreal’s Royalty Pharma RPRX Stock Holding History

Bank of Montreal’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.34M Buy
+130,885
New +$6.81M ﹤0.01% 1255
2025
Q4 		– Sell
-109,939
Closed -$3.88M – 3800
2025
Q3 		$3.88M Sell
109,939
-12,057
-10% -$436K ﹤0.01% 1407
2025
Q2 		$4.4M Buy
121,996
+220
+0.2% +$7.29K ﹤0.01% 1294
2025
Q1 		$3.79M Sell
121,776
-22,697
-16% -$719K ﹤0.01% 1276
2024
Q4 		$3.69M Sell
144,473
-301,464
-68% -$7.99M ﹤0.01% 1327
2024
Q3 		$12.6M Buy
445,937
+290,019
+186% +$8.03M 0.01% 948
2024
Q2 		$4.2M Sell
155,918
-32,429
-17% -$899K ﹤0.01% 1340
2024
Q1 		$5.73M Buy
188,347
+10,561
+6% +$311K ﹤0.01% 1164
2023
Q4 		$5.1M Sell
177,786
-227,201
-56% -$6.24M ﹤0.01% 1275
2023
Q3 		$11.6M Sell
404,987
-24,887
-6% -$739K ﹤0.01% 924
2023
Q2 		$13.8M Buy
429,874
+54,989
+15% +$1.86M ﹤0.01% 880
2023
Q1 		$13.6M Buy
374,885
+199,747
+114% +$7.41M 0.01% 815
2022
Q4 		$6.93M Buy
175,138
+24,495
+16% +$1.02M ﹤0.01% 1143
2022
Q3 		$6.25K Buy
150,643
+14,154
+10% +$605K ﹤0.01% 1238
2022
Q2 		$5.83K Sell
136,489
-6,569
-5% -$269K ﹤0.01% 1333
2022
Q1 		$5.58M Sell
143,058
-14,369
-9% -$564K ﹤0.01% 1433
2021
Q4 		$6.37M Sell
157,427
-10,833
-6% -$421K ﹤0.01% 1139
2021
Q3 		$6.18M Buy
168,260
+42,881
+34% +$1.67M ﹤0.01% 1528
2021
Q2 		$5.16M Buy
125,379
+1,943
+2% +$82.6K ﹤0.01% 1593
2021
Q1 		$5.18M Sell
123,436
-16,955
-12% -$804K ﹤0.01% 1325
2020
Q4 		$7.21M Buy
140,391
+9,560
+7% +$406K ﹤0.01% 1198
2020
Q3 		$5.73M Buy
+130,831
New +$5.61M ﹤0.01% 1119

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bank of Montreal's RPRX Position: Q2 2026 in Review

Bank of Montreal opened a new position in Royalty Pharma (RPRX) in Q2 2026: 130,885 shares worth $7.34M. The stake represents ﹤0.01% of the portfolio and ranks #1255 among its holdings. This is a return to the name: Bank of Montreal previously reported a position in RPRX as recently as Q3 2025.

Bank of Montreal first reported a position in RPRX in Q3 2020 and has held it in 22 quarters since. The position peaked at $13.8M in Q2 2023. 498 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Bank of Montreal held 130,885 shares of Royalty Pharma worth $7.34M as of Q2 2026.
  • Royalty Pharma was a new Bank of Montreal position in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1255 holding.
  • Bank of Montreal first reported a position in Royalty Pharma in Q3 2020 and has held it in 22 quarters since.
  • Bank of Montreal's Royalty Pharma position peaked at $13.8M in Q2 2023.
  • 498 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.